ReProtect Inc
Quick facts
Phase 2 pipeline
- Drug: BufferGel® with diaphragm · Infectious Disease / Sexual Health
BufferGel is a vaginal microbicide gel that buffers vaginal pH to create an acidic environment hostile to HIV and other sexually transmitted pathogens, used in conjunction with a diaphragm for contraceptive and prophylactic protection.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies